191 related articles for article (PubMed ID: 17922408)
1. Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection.
Lupetti A; Brouwer CP; Bogaards SJ; Welling MM; de Heer E; Campa M; van Dissel JT; Friesen RH; Nibbering PH
J Infect Dis; 2007 Nov; 196(9):1416-24. PubMed ID: 17922408
[TBL] [Abstract][Full Text] [Related]
2. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
Navarathna DH; Hornby JM; Hoerrmann N; Parkhurst AM; Duhamel GE; Nickerson KW
J Antimicrob Chemother; 2005 Dec; 56(6):1156-9. PubMed ID: 16239285
[TBL] [Abstract][Full Text] [Related]
3. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
4. Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis.
Hope WW; Drusano GL; Moore CB; Sharp A; Louie A; Walsh TJ; Denning DW; Warn PA
Antimicrob Agents Chemother; 2007 Jan; 51(1):285-95. PubMed ID: 17088486
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
Khan MA; Khan A; Owais M
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
[TBL] [Abstract][Full Text] [Related]
6. The effects of human lactoferrin in experimentally induced systemic candidiasis.
Velliyagounder K; Rozario SD; Fine DH
J Med Microbiol; 2019 Dec; 68(12):1802-1812. PubMed ID: 31702539
[No Abstract] [Full Text] [Related]
7. Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin.
Lupetti A; Brouwer CP; Dogterom-Ballering HE; Senesi S; Campa M; Van Dissel JT; Nibbering PH
J Antimicrob Chemother; 2004 Sep; 54(3):603-8. PubMed ID: 15282237
[TBL] [Abstract][Full Text] [Related]
8. Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis.
Wang Y; Jia XM; Jia JH; Li MB; Cao YY; Gao PH; Liao WQ; Cao YB; Jiang YY
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e40-6. PubMed ID: 19413603
[TBL] [Abstract][Full Text] [Related]
9. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ
J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
11. Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
Shi J; Li S; Gao A; Zhu K; Zhang H
Phytomedicine; 2018 Jul; 46():21-31. PubMed ID: 30097119
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.
Petraitiene R; Petraitis V; Kelaher AM; Sarafandi AA; Mickiene D; Groll AH; Sein T; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2005 May; 49(5):2084-92. PubMed ID: 15855534
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
Ghannoum MA; Kim HG; Long L
J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
[TBL] [Abstract][Full Text] [Related]
14. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
[TBL] [Abstract][Full Text] [Related]
15. Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis.
Lee JH; Jang EC; Han Y
Arch Pharm Res; 2011 Mar; 34(3):399-405. PubMed ID: 21547671
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
[TBL] [Abstract][Full Text] [Related]
17. Candidacidal activities of human lactoferrin peptides derived from the N terminus.
Lupetti A; Paulusma-Annema A; Welling MM; Senesi S; van Dissel JT; Nibbering PH
Antimicrob Agents Chemother; 2000 Dec; 44(12):3257-63. PubMed ID: 11083624
[TBL] [Abstract][Full Text] [Related]
18. Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial αβ region.
Kondori N; Baltzer L; Dolphin GT; Mattsby-Baltzer I
Int J Antimicrob Agents; 2011 Jan; 37(1):51-7. PubMed ID: 21075607
[TBL] [Abstract][Full Text] [Related]
19. Antibiotics produced by Streptomyces olivaceus 142. Antifungal properties of antibiotic WR-142 FPG.
Wieczorek J; Mordarski M
Arch Immunol Ther Exp (Warsz); 1979; 27(3):433-9. PubMed ID: 383040
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
